By Adam Clark
Sensyne Health PLC said Tuesday that it has initiated a formal sales process after its chief executive officer and largest shareholder, Paul Drayson, approached the board about a potential management buyout of the company.
The clinical artificial-intelligence company said the board has appointed J.P. Morgan Cazenove and Peel Hunt to consider a management buyout proposal and explore other buyer interest, alongside strategic options such as the continued pursuit of a secondary U.S. listing.
Neither the company nor Mr. Drayson are currently in discussions with any potential offeror, nor has any offer been made, Sensyne Health said.
Write to Adam Clark at email@example.com